Nasrollah Eslami, MD
Neurology · Alabaster, ALNPI 1235147232
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. Livanova USA, Inc. accounts for 60.7% of it on its own, with 11 other manufacturers making up the rest. 2023 is the largest year on record at $1,847, 3.8 times the $487 reported in 2019. That places this record below the midpoint for neurology clinicians in AL, where the typical reported total is $2,219.
Across 44 payments — averaging $70.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$2K
- Greenwich Biosciences, Inc.$184
- UCB, Inc.$171
- Abbott$135
- MDD US Operations, LLC$125
- Lilly USA, LLC$122
- plus $479 from 6 others
What the payments were for
- Travel & lodging$1,49848%
- Food & beverage$1,58951%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 11 | $1,880 |
| Greenwich Biosciences, Inc. | 3 | $184 |
| UCB, Inc. | 8 | $171 |
| Abbott | 1 | $135 |
| MDD US Operations, LLC | 1 | $125 |
| Lilly USA, LLC | 1 | $122 |
| Alnylam Pharmaceuticals Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 5 | $99 |
| SK Life Science, Inc. | 3 | $90 |
| AbbVie(2 entities) | 5 | $82 |
| Supernus Pharmaceuticals, Inc. | 3 | $45 |
| Amgen | 2 | $42 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,767
- Epidiolex$148
- MitraClip$135
- APOKYN$125
- ONPATTRO$122
How this compares
$3,095 in reported general payments places this provider in the 50th percentile of 255 neurology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine | 39 | $1,425 |
| Pyridostigmine Bromide | 14 | $1,033 |
| Levetiracetam | 20 | $972 |
| Primidone | 17 | $738 |
| Memantine Hcl | 18 | $649 |
| Topiramate | 32 | $535 |
| Donepezil Hcl | 11 | $157 |
| Tizanidine Hcl | 13 | $138 |
Paid to pharmacies, not to this prescriber.
Other neurology in Alabaster
- Diane CounceBirmingham$895K
- Daniel DeesMobile$799K
- Christopher LagankeCullman$711K
- Hayden LongMobile$386K
- Harry McDarisHuntsville$307K
- Belinda Savage-EdwardsHuntsville$296K
- Emily RiserBirmingham$231K
- Nojan ValadiOpelika$219K
- Charles MarkleMobile$212K
- Timothy PrestleyTuscaloosa$210K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.